期刊文献+

Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment 被引量:12

Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment
下载PDF
导出
摘要 Pancreatic neuroendocrine tumors (PNETs), a group of endocrine tumors arising in the pancreas, are among the most common neuroendocrine tumors. The genetic causes of familial and sporadic PNETs are somewhat understood, but their molecular pathogenesis remains unknown. Most PNETs are indolent but have malignant potential. The biological behavior of an individual PNET is unpredictable; higher tumor grade, lymph node and liver metastasis, and larger tumor size generally indicate a less favorable prognosis. Endocrine testing, imaging, and histological evidence are necessary to accurately diagnose PNETs. A 4-pronged aggressive treatment approach consisting of surgery, locoregional therapy, systemic therapy, and complication control has become popular in academic centers around the world. The optimal application of the multiple systemic therapeutic modalities is under development; efficacy, safety, availability, and cost should be considered when treating a specific patient. The clinical presentation, diagnosis, and treatment of specific types of PNETs and familial PNET syndromes, including the novel Mahvash disease, are summarized. Pancreatic neuroendocrine tumors (PNETs), a group of endocrine tumors arising in the pancreas, are among the most common neuroendocrine tumors. The genetic causes of familial and sporadic PNETs are somewhat understood, but their molecular pathogenesis remains unknown. Most PNETs are indolent but have malignant potential. The biological behavior of an individual PNET is unpredictable; higher tumor grade, lymph node and liver metastasis, and larger tumor size generally indicate a less favorable prognosis. Endocrine testing, imaging, and histological evidence are necessary to accurately diagnose PNETs. A 4-pronged aggressive treatment approach consisting of surgery, Iocoregional therapy, systemic therapy, and complication control has become popular in academic centers around the world. The optimal application of the multiple systemic therapeutic modalities is under development; efficacy, safety, availability, and cost should be considered when treating a specific patient. The clinical presentation, diagnosis, and treatment of specific types of PNETs and familial PNET syndromes, including the novel Mahvash disease, are summarized.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2013年第6期312-324,共13页
关键词 肿瘤生物学 神经内分泌 全身治疗 胰腺 诊断 生物学行为 发病机制 学术中心 Pancreatic neuroendocrine tumors insulinoma gastrinoma VlPoma glucagonoma non-functioning multiple endocrine neoplasia syndrome type 1 Mahvash disease
  • 相关文献

参考文献3

二级参考文献107

  • 1Kimura W, Kuroda A, Morioka Y. Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci 1991; 36:933-942.
  • 2Thompson NW, Lloyd RV, Nishiyama RH, Vinik AL Strodel WE, Allo MD, Eckhauser FE, Talpos G, Mervak T. MEN I pancreas: a histological and immunohistochemical study. World J Surg 1984; 8:561-574.
  • 3Anlauf M, Schlenger R, Perren A, Bauersfeld J, Koch CA, Dralle H, Raffel A, Knoefel WT, Weihe E, Ruszniewski P, Couvelard A, Komminoth P, Heitz PU, Kloppel G. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome. Am J Surg Patho12006; 30:560-574.
  • 4Lubensky IA, Pack S, Ault D, Vortmeyer AO, Libutti SK, Choyke PL, Walther MM, Linehan WM, Zhuang Z. Multiple neuroendocrine tumors of the pancreas in yon Hippel-Lindau disease patients: histopathological and molecular genetic analysis. Am J Pathol 1998; 153:223-231.
  • 5Perigny M, Hammel P, Corcos O, Larochelle O, Giraud S, Richard S, Sauvanet A, Belghiti J, Ruszniewski P, Bedossa P, Couvelard A. Pancreatic endocrine microadenomatosis in patients with yon Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression. Am J Surg Pathol 2009; 33: 739-748.
  • 6Bouwens L, Rooman I. Regulation of pancreatic beta-cell mass. Physiol Rev 2005; 85:1255-1270.
  • 7Gleason CE, Gross DN, Birnbaum MJ. When the usual insulin is just not enough. Proc Natl Acad Sci USA 2007; 104: 8681-8682.
  • 8Hofeldt FD. Reactive hypoglycemia. Endocrinol Metab Clin North Am 1989; 18:185-201.
  • 9Brun JF, Fedou C, Mercier J. Postprandial reactive hypoglycemia. Diabetes Metab 2000; 26:337-351.
  • 10Rahier J, Falt K, Muntefering H, Becker K, Gepts W, Falkmer S. The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? Diabetologia 1984; 26:282-289.

共引文献51

同被引文献48

引证文献12

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部